Online ISSN: 2515-8260

Study of Pyrazinamide Induced Hyperuricemia in Patients Undergoing DOTS Therapy for Tuberculosis at Tertiary Health Centre, Jhalawar (Rajasthan)

Main Article Content

Dr. Rajendra Babu Mathur1*, Dr. Amit Kumar Sharma2 , Dr. Krishna Murari3*, Dr. Ajay Kumar Bhargava

Abstract

Background: Tuberculosis remains a global health problem despite of available anti tubercular treatment (ATT). Frequent discontinuation from treatment is a major factor due to associated adverse effects of drugs. Objective: Altered Serum Uric Acid (SUA) Levels due to potent ATT drug, Pyrazinamide is being given under NTEP

Article Details